当前位置: X-MOL 学术Ann. Anat. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Simvastatin accelerates the healing process of burn wound in Wistar rats through Akt/mTOR signaling pathway
Annals of Anatomy ( IF 2.0 ) Pub Date : 2020-12-02 , DOI: 10.1016/j.aanat.2020.151652
Parisa Ramhormozi 1 , Javad Mohajer Ansari 2 , Sara Simorgh 3 , Hamid Reza Asgari 4 , Mohammad Najafi 5 , Mahmood Barati 6 , Azar Babakhani 4 , Maliheh Nobakht 7
Affiliation  

Statins, apart from cholesterol-lowering properties, have wound healing effects. Hereby, we aimed to assess the impact of Simvastatin (SMV), one of the most commonly used statins, on Akt/mTOR signaling pathway during burn wound healing process. After creating a second-degree burn on the dorsal area of adult male Wistar rats (n = 60), they were randomly divided into the control, SMV, vehicle of Simvastatin (SMV-Veh), Rapamycin (RM), vehicle of Rapamycin (RM-Veh), and combined SMV and RM (SMV + RM) groups. The animals were sacrificed on the 7th and 14th post-burn days and wound tissue samples were collected for histologic, immunohistochemical, quantitative real-time polymerase chain reaction (qRT-PCR), and western blot investigations. Rapamycin (RM) was also used to treat animals as an mTOR inhibitor. Topical administration of SMV resulted in a faster healing rate, elevated collagen deposition, and increased myofibroblast population compared to other experimental groups. Moreover, qRT-PCR findings showed that the wounds treated with SMV alone had the highest expression levels of CD31, VEGF, Akt, mTOR, and p70S6K after 7 and 14 days of burn model (p < 0.001). According to western blot findings, daily topical treatment with SMV further increased protein levels of P-AktThr308, P-mTORSer2448, and P-p70S6 KThr389 compared with other treatments, at both follow-up time points (p < 0.001). In contrast, inhibition of Akt/mTOR signaling pathway by RM reduced SMV-induced wound healing process. Seemingly, SMV promotes burn wound healing, at least in part, through activating Akt/mTOR signaling pathway, suggesting topically applied SMV as an alternative therapeutic approach for managing burn wound healing.



中文翻译:

辛伐他汀通过 Akt/mTOR 信号通路加速 Wistar 大鼠烧伤创面愈合过程

他汀类药物除了具有降低胆固醇的特性外,还具有伤口愈合作用。因此,我们旨在评估最常用的他汀类药物之一辛伐他汀 (SMV) 在烧伤伤口愈合过程中对 Akt/mTOR 信号通路的影响。在成年雄性 Wistar 大鼠(n = 60)的背部产生二度烧伤后,将它们随机分为对照、SMV、辛伐他汀载体(SMV-Veh)、雷帕霉素(RM)、雷帕霉素载体( RM-Veh),以及合并的 SMV 和 RM (SMV + RM) 组。在烧伤后第 7 天和第 14 天处死动物,收集伤口组织样本用于组织学、免疫组织化学、定量实时聚合酶链反应 (qRT-PCR) 和蛋白质印迹研究。雷帕霉素 (RM) 也用于治疗动物作为 mTOR 抑制剂。与其他实验组相比,SMV 的局部给药导致更快的愈合速度、增加的胶原沉积和增加的肌成纤维细胞数量。此外,qRT-PCR 结果显示,仅用 SMV 治疗的伤口在烧伤模型 7 天和 14 天后 CD31、VEGF、Akt、mTOR 和 p70S6K 的表达水平最高。p < 0.001)。根据蛋白质印迹结果,在两个随访时间点,与其他治疗相比,每天用 SMV 局部治疗进一步增加了 P-Akt Thr308、P-mTOR Ser2448和 P-p70S6 K Thr389 的蛋白质水平(p < 0.001)。相反,RM 对 Akt/mTOR 信号通路的抑制减少了 SMV 诱导的伤口愈合过程。表面上,SMV 至少部分通过激活 Akt/mTOR 信号通路促进烧伤伤口愈合,表明局部应用 SMV 作为管理烧伤伤口愈合的替代治疗方法。

更新日期:2020-12-02
down
wechat
bug